Efficacy Study of GS010 for the Treatment of Vision Loss up to 6 Months From Onset in LHON Due to the ND4 Mutation
Clinical trial NCT02652767 · COMPLETED
Trial details
- NCT number
- NCT02652767
- Sponsor
- GenSight Biologics
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-23
- Primary completion
- 2018-08-07
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.